HARC Center: HIV Accessory and Regulatory Complexes
HARC 中心:HIV 辅助和调节复合体
基本信息
- 批准号:9410900
- 负责人:
- 金额:$ 484.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-27 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAntibodiesBiologicalBiological AssayBiologyCRISPR/Cas technologyCell physiologyCellsClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesComplementComplexCryoelectron MicroscopyDNADetectionDevelopmentElectron MicroscopyEnsureEnzymesEventEvolutionFunding OpportunitiesGeneticGenetic TranscriptionGenetic studyGoalsHIVHIV-1Host DefenseHumanIn VitroIndividualInterdisciplinary StudyInterventionLabelLaboratoriesLeadLearningLife Cycle StagesLightLipidsMass Spectrum AnalysisMembraneMembrane LipidsMembrane ProteinsMethodologyMethodsMissionModelingMolecularMutationNucleic AcidsOther GeneticsPathogenesisPathway interactionsPatientsPeptidesPeroxidasesPharmaceutical PreparationsPositive Transcriptional Elongation Factor BPost-Translational Protein ProcessingProgram DevelopmentProteinsProteomicsRNARegimenRegulationResearchResearch PersonnelResidenciesResolutionResourcesRoentgen RaysScientistSeedsSeriesSisterSourceStructureSystemT-LymphocyteTNFRSF5 geneTechniquesTechnologyTherapeuticTherapeutic InterventionTractionTrainingUbiquitinationValidationViralVirusWorkX-Ray Crystallographyascorbatebeamlinecofactorcohortdata sharingdrug efficacyflexibilitygenetic approachgenetic informationgenetic regulatory proteinimprovedin vivoinnovationinsightmembermolecular imagingnanodisknef Proteinnew technologynext generationnovelnovel therapeutic interventionoutreachprogramsprotein complexprotein expressionresistance mutationrev Proteinscaffoldscreeningstructural biologysymposiumtat Proteintechnology trainingtherapeutic targettitanium dioxidetooltraffickingtreatment strategyvif Gene Productsvirologyvirus geneticsvpu Protein
项目摘要
CENTERS FOR HIV/AIDS-RELATED STRUCTURAL BIOLOGY (P50)
HARC CENTER: HIV ACCESSORY AND REGULATORY COMPLEXES
OVERALL SUMMARY
The HARC Center is an integrated program proposed by investigators whose overarching goal is to improve
understanding of the interactions between HIV accessory and regulatory proteins and host cellular systems to
enable eventual expansion of therapeutic approaches. There are currently no HIV therapeutics targeting any
of the proteins on which the HARC Center is focused (HIV-1 Vif, Vpu, Nef, Tat and Rev proteins and their
interacting viral and cellular partners). The scientific focus of the Center is on determining structures of these
complexes, using an integrated Systems to Structure pipeline that includes (1) Discovery, through novel
methods of functional proteomics and genetics being developed in the HARC Center, (2) Validation through
breakthrough CRISPR methods in primary T cells as well as targeted in vivo and in vitro functional assays, and
(3) Structure Determination using a synthesis of innovative structural techniques developed in the HARC
Center to address the large, flexible, heterogeneous and sometimes membrane-associated systems we study.
We are focused on two themes aimed at understanding the biological questions surrounding HIV replication
and persistence in the host cell. These include how the virus counteracts host restriction mechanisms (Theme
1: “Counteracting”) and how the virus hijacks host systems for viral transcription and RNA export/trafficking
to ensure continuation of the viral life cycle (Theme 2: “Hijacking”). The seven projects proposed here
include: (1) Structure and Evolution of APOBEC3-Vif Interactions, (2) Regulation of Vif and Rewiring of Host
Pathways, (3) The Multiple Functions of Vpu at the Membrane, (4) Nef Interaction Networks at the Membrane,
(5) Tat-Host Transcription Complexes, (6) Structure and Dynamics of Rev and RNA-Host Complexes, and (7)
Characterization of “Super Restriction Factors” and Prediction of Host-HIV Interfaces. The HARC Center
projects are supported by an administrative core and seven technology cores essential for their completion: (1)
Proteomic Approaches to HIV Function, (2) CRISPR in Primary Cells to Study HIV-Host Function, (3)
Molecular Imaging Using Cryo-Electron Microscopy (EM), (4) Application and Development of Antibody Tools,
(5) Integrative Modeling of HIV-Human Complexes, (6) X-ray Screening and Rapid Structure Determination,
and (7) Membrane Protein Expression/Purification.
We are committed to collaborating with Sister Centers and the HIV research community as well as training the
next generation of investigators. We create and support opportunities including the Technology Training
Residency to bring young investigators to learn in our Center's Cores, and we seed new research through the
Collaborative Opportunity Fund, along with holding events such as seminars and an annual symposium.
艾滋病毒/艾滋病相关结构生物学中心(p50)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nevan J Krogan其他文献
Nevan J Krogan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nevan J Krogan', 18)}}的其他基金
HARC: HIV accessory and regulatory complexes
HARC:HIV 附件和调节复合体
- 批准号:
10506980 - 财政年份:2022
- 资助金额:
$ 484.53万 - 项目类别:
Core 1: Functional Genomics and Proteomics
核心1:功能基因组学和蛋白质组学
- 批准号:
10704617 - 财政年份:2022
- 资助金额:
$ 484.53万 - 项目类别:
Core 1: Functional Genomics and Proteomics
核心1:功能基因组学和蛋白质组学
- 批准号:
10525592 - 财政年份:2022
- 资助金额:
$ 484.53万 - 项目类别:
International West Africa Symposium and Workshop on Infectious Diseases
国际西非传染病研讨会暨讲习班
- 批准号:
10540552 - 财政年份:2022
- 资助金额:
$ 484.53万 - 项目类别:
HARC: HIV accessory and regulatory complexes
HARC:HIV 附件和调节复合物
- 批准号:
10666644 - 财政年份:2022
- 资助金额:
$ 484.53万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 484.53万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 484.53万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 484.53万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 484.53万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 484.53万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 484.53万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 484.53万 - 项目类别:














{{item.name}}会员




